HS Heading 3003
Medicaments; (not goods of heading no. 3002, 3005 or 3006) of two or more constituents mixed together for therapeutic or prophylactic use not in measured doses or in forms or packings for retail sale
14 tariff lines in this heading, within chapter 30 (Pharmaceutical products). Click any HS code for the full breakdown and a duty calculation.
| HS Code | Description | CD | SD | VAT | AIT | RD | AT | TTI |
|---|---|---|---|---|---|---|---|---|
| 30031000 | Medicaments Containing Penicillins..Or Streptomycins..,Not For Retail Sale | 5 | 0 | 0 | 5 | 0 | 0 | 10% |
| 30032000 | Medicaments Containing Other Antibiotics, ....Not For Retail Sale | 5 | 0 | 0 | 5 | 0 | 0 | 10% |
| 30033100 | Insulin, Not For Retail Sale | 0 | 0 | 0 | 5 | 0 | 0 | 5% |
| 30033910 | Anti-malaria-TB-cancer-leprosy,cardiovascular,anti-hepatic drug kidney dialysis solu. | 0 | 0 | 0 | 5 | 0 | 0 | 5% |
| 30033990 | Excl..Anti-malaria-TB-cancer...cardiovascular,anti-hepatic drug kidney dialysis solu. | 5 | 0 | 0 | 5 | 0 | 0 | 10% |
| 30034100 | Other, containing alkaloids or derivatives thereof containing ephedrine or its salts | 5 | 0 | 0 | 5 | 0 | 0 | 10% |
| 30034200 | Other, containing alkaloids or derivatives thereof, containing pseudoephedrine (inn) | 5 | 0 | 0 | 5 | 0 | 0 | 10% |
| 30034300 | Other, containing alkaloids or derivati..thereof containing norephedrine or its salts | 5 | 0 | 0 | 5 | 0 | 0 | 10% |
| 30034910 | Anti-malaria, anti-TB, anti-cancer, anti-leprosy, cardiovascular and anti-hepatic en | 0 | 0 | 0 | 5 | 0 | 0 | 5% |
| 30034990 | Medicaments (Excl. goods of heading No. 3002 .... not for retails sale, NES | 5 | 0 | 0 | 5 | 0 | 0 | 10% |
| 30036000 | Other, containing antimalarial active principles described in Subheading Note 2 ... | 0 | 0 | 15 | 5 | 0 | 7.5 | 27.5% |
| 30039010 | Other Medicaments With>=2 Constitu..Containing More Then 15%Absolt.Alcohol | 25 | 0 | 15 | 5 | 5 | 7.5 | 64.25% |
| 30039091 | Other Anti-Malaria,Anti-Tb,A.-Leprosy Cardiovascular & A.-Hepatic Encep... | 0 | 0 | 0 | 5 | 0 | 0 | 5% |
| 30039099 | Other medicaments with >=2 constituents, not for retail sale, nes | 5 | 0 | 0 | 5 | 0 | 0 | 10% |
Recorded imports
Between December 2025 and May 2026, NBR recorded commercial imports worth BDT 387,475,983 (17,002 kg) under this heading, across 6 of its 14 tariff lines. The remaining 8 recorded no commercial import in that window.
| Month | Lines with imports | Net weight | Assessable value |
|---|---|---|---|
| December 2025 | 3 | 4,988 kg | BDT 73,244,677 |
| January 2026 | 4 | 510 kg | BDT 56,239,350 |
| February 2026 | 3 | 575 kg | BDT 83,363,701 |
| March 2026 | 4 | 200 kg | BDT 48,619,303 |
| April 2026 | 6 | 9,790 kg | BDT 61,157,926 |
| May 2026 | 2 | 939 kg | BDT 64,851,026 |
The largest lines by assessable value in May 2026:
Import figures: NBR Import Statements (IM-4 commercial), December 2025 – May 2026. Assessable value is the customs value on which duty is charged, not the retail or invoice price.